EMA approves Oryzon’s application for Phase II HOPE-2 study
The single-arm, single-centre, open-label trial will evaluate vafidemstat in 12 adult patients in Spain.
Clinical Trials
Patient enrolment concludes in Vasomune’s Phase IIa Pegevongitide trial
Akeso begins Phase III study of cadonilimab for gastric cancer
Innovent expands Phase III MarsLight-11 trial to non-squamous NSCLC
Milestone begins Canadian enrolment in Phase III AFib-RVR trial
Clywedog reports final Phase Ib trial results for balomenib
Optimi Health produces psilocybin capsules for Phase II MDD study
Roivant reports top-line data from IMVT-1402 CLE trial
